Kennedy Capital Management, Inc. Avenue Therapeutics, Inc. Transaction History

Kennedy Capital Management, Inc.

  • $4.55 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$9.37 - $12.06 $564,336 - $726,349
-60,228 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$8.29 - $11.47 $43,025 - $59,529
5,190 Added 9.43%
60,228 $649,000
Q1 2020

May 15, 2020
BUY
$6.44 - $11.32 $354,444 - $623,030
55,038 New
55,038 $492,000

About AVENUE THERAPEUTICS, INC.

ATXI Quotes by TradingView
  • Ticker ATXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,127,720
  • Market Cap $13.8M
  • Description
  • Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...
More about ATXI
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email